These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 29796120)

  • 21. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
    Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer.
    He T; Zhang M; Zheng R; Zheng S; Linghu E; Herman JG; Guo M
    Epigenomics; 2017 Jun; 9(6):849-862. PubMed ID: 28403629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.
    Kano H; Takayama T; Midorikawa Y; Nagase H
    Biosci Trends; 2016 Jul; 10(3):202-9. PubMed ID: 27301432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
    Piazzi G; Selgrad M; Garcia M; Ceccarelli C; Fini L; Bianchi P; Laghi L; D'Angelo L; Paterini P; Malfertheiner P; Chieco P; Boland CR; Bazzoli F; Ricciardiello L
    Br J Cancer; 2013 Apr; 108(8):1750-6. PubMed ID: 23579212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
    Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypermethylation of NDN promotes cell proliferation by activating the Wnt signaling pathway in colorectal cancer.
    Hu YH; Chen Q; Lu YX; Zhang JM; Lin C; Zhang F; Zhang WJ; Li XM; Zhang W; Li XN
    Oncotarget; 2017 Jul; 8(28):46191-46203. PubMed ID: 28521288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
    J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
    Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
    Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer.
    Kou C; Zhou T; Han X; Zhuang H; Qian H
    Biochem Biophys Res Commun; 2015 Aug; 464(2):519-25. PubMed ID: 26159916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.
    Liu X; Chen X; Zeng K; Xu M; He B; Pan Y; Sun H; Pan B; Xu X; Xu T; Hu X; Wang S
    Cell Death Dis; 2018 Oct; 9(10):1037. PubMed ID: 30305607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling.
    Chen L; Tang J; Feng Y; Li S; Xiang Q; He X; Ren G; Peng W; Xiang T
    Cell Physiol Biochem; 2017; 44(4):1370-1380. PubMed ID: 29186710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.
    Dong Z; Dai L; Zhang Y; Fang C; Shi G; Chen Y; Li J; Wang Q; Fu J; Yu Y; Wang W; Cheng L; Liu Y; Lin Y; Wang Y; Wang Q; Wang H; Zhang H; Zhang Y; Su X; Zhang S; Wang F; Qiu M; Zhou Z; Deng H
    PLoS Genet; 2020 Nov; 16(11):e1009159. PubMed ID: 33175846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma.
    Kumar A; Gosipatala SB; Pandey A; Singh P
    Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
    Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
    Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
    Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
    Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.